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The Introduction of this thesis illustrates the general acceptance of kidney and
liver transplantation as a routine procedure in clinical practice. It also shows the
enormous increase over the years of the number of patients, waiting for an
organ. As a result, due to an increased demand for suitable donororgans, criteria
ofacceptance for organdonors were extended and, consequently, the percentage
of primary nonfunction(PNF), delayed graft function(DGF) and initial poor
function(IPF) in liver transplantation and delayed graft function in kidney
transplantation have increased.
Currently, simple cold storage of donororgans in the University of Wisconsin
(IJW) organ preservation solution is the preferred method of preservation.
Chapter.I also describes the initial start of organ preservation by the method of
hypothermic machine perfusion, but focuses in general on the development of
preservation solutions and in essence on the concept of the UW cold storage
solution.
The clinical problem of PNF, DGF and IPF in the UW era is probably related
to changes that organs undergo during cold storage or during normothermic
reperfusion after transplantation. The potential mechanisms, which might play
an injurious role to these organs during preservation and reperfusion, are
described. There is no consensus about the contribution ofoxygen free radicals
to preservation/reperfusion damage of organs. Belzer and Southard at the
University of Wisconsin, however, felt that free radicals might disrupt cell
metabolism and cause cell injury. For this reason glutathione, an oxygen free
radical scavenger, was included in the UW solution. The importance of
glutathione, however, has been widely discussed and supportive evidence that
one of the constituent amino acids of glutathione, such as glycine, might have
the same protective capacities as glutathione has been described in this chapter.
Finally, a justification of the different preservation and reperfusion models used
in this thesis has been siven.
CHaprsn II
In this chapter the rationale of the studies which are included in this thesis is
presented. The studies concern preservation experiments in the rabbit liver,
comparing UW solution, HTK solution and PBS (Chapter III). In different
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kidney transplantation (Chapters IV-VI) and liver transplantation (Chapters VII
and VIII) have been described.
CHeprgn III
The University of Wisconsin solution (UW) is a relatively complex mixture of
agents that has been shown to be effective for preservation of the pancreas,
liver, kidney, and heart. Simpler solutions such as histidinetryptophan-
ketoglutarate (HTK) and phosphate buffered sucrose (PBS) are effective for
preservation ofthe kidney and during the last years centers have started to use
HTK in clinical liver transplantation. Because the composition of these
solutions is considerably different from UW solution, we were interested to see
how these would perform in liver preservation. In addition, we investigated how
replacement of hydroxyethyl starch (FDS) with another colloid, polyethylene
glycol (PEG), in UW solution affected preservation efficacy. This information
could provide clues to the mechanism of action of components of preservation
solutions and help in designing improved preservatives.
Rabbit livers were cold stored for either 24 or 48 h and preservation quality
judged by performance during two hours of isolated perfusion (Krebs-Henseleit
Buffer) a|37" Celsius (C). Bile produced, release of intracellular enzymes into
the perfusate (AST and LDH) and total tissue water content (TTW) and
electrolyte content (K. and Na*) at the end of reperfusion were used to compare
preservation efficacy.
Af\er 24 h preservation the amount of bile produced in UW preserved livers
(8.4 t 0.5 mll2 h/100 g liver tissue) was significantly greater Qt < 0.05) than in
HTK preserved livers (6.5 t 0.8 mll2 h/100 g). Also, there was less LDH
released into the perfusate in UW preserved livers (375 + 38 U/100 g versus
792 + 207 U1100 E, p < 0.05). In addition, AST release was greater from livers
preserved in HTK (not significant) and there was more edema Qt < 0.05) and
lower K*A.Ia* ratios (p < 0.05) in HTK preserved livers versus UW preserved
livers.
After 48 h preservation there was greater injury to the livers preserved in
UW or HTK versus 24 h preserved livers. The differences between livers
preserved for 48 h in UW or HTK were less noticeable than at 24 h and bile
production was similar. LDH and AST release were greater in HTK preserved
livers than in UW preserved livers (LDH :1494 + 460 U/100 g versus 881 +
136 U/100 g and AST :  158 + 2l  Ul l00 g versus l l7 + 17 U/100 g),  but the
differences did not reach significance at p < 0.05. Livers preserved in PBS for
48 h showed significantly more injury (less bile production, greater enzyme
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Chupter IX
release, more edema and lower KtA{a* ratio) than livers preserved in HTK or
UW. Substitution of PEG (8000 or 20,000 daltons) for FIES in UW livers
preserved for 48 h was not effective and bile production was worse, enzyrne
release greater. the tissue more edematous and contained a lower K-/Na* ratio at
the end of reperfusion than livers preserved with HES (differences significant
versus UW livers).
This study shows that at 24 h preservation in UW solution some indices
showed significant improvement over HTK, while others were not different in
preserving the rabbit liver as tested by isolated perfusion. After 48 h
preservation the differences narïow, although some measures of liver
performance are better preserved in UW solution. PBS preservation at 48 h was
worse than either HTK or UW and PEG is not a good substitute for HES in UW
solution. Solutions, simpler in composition than the UW solution, may be
efïective for short term kidney preservation, but do not appear suitable for
successful liver preservation.
Crnp-r'pR IV
Chapter IV describes in a renal slices model of rat kidneys the potential
cytoprotective qualities of glycine. The addition of 10 rnM/L glycine to a
preservation medium KHB showed a statistically significant decrease inYoLDH
release during 24-72 h of preservation (40C.1 and thereafter rewanned for 2 h
(37'C) in KFIB. The addition of l0 mM/L glycine to the reperfusion medium
KHB, after 0-72 h cold storage in KHB without glycine, resulted even in a more
pronounced cytoprotective effect of glycine. No statistical significant effect on
cell ederna or tissue ATP content was found in both studies during all
preservation periods.
Subsequently, the results of these experiments were also tested in vivo. Dog
kidneys were harvested, cold stored for 72 h in UW solution with and without
glutathione and autotransplanted (Group A and B). A third group (Group C)
was cold stored for 12 h in UW solution, in which glutathione was replaced by
15 mM/L glycine.
Sur",rival was only 50oÁin Group B versus Group A and C (100%) and serum
creatinine values remained significantly high in Group B during the observation
period. It is concluded that glycine may offer protection to the hypotherrnically
preserved kidney, but does not appear to be as protective as glutathione.
As a result of these preliminary data, more extensive experiments on glycine
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Cueprsn V
Both, glutathione and the amino acid glycine, have been shown to be
cytoprotective against hypoxic and ischemic injury in a number of organs in
different animal modeis.
It has been suggested that the molecular mechanism of this protection is
possibly related to a membrane stabilizing effecÍ of glycine. In the study
included in this chapter the effect of glycine was evaluated on phospholipase
Ar-induced membrane degradation in proximal renal tubules of the rabbit and in
raÍ hepatocytes. Glycine, given before and during reperfusion of cells,
significantly reduced extracellular and intracellular phospholipase A, induced
membrane degradation in both cell types, as well as arachidonic acid release in
renal tubules. intracellular phospholipase A, release in renal tubules, activated
by the Ca** ionophore A 23187 and the bee venom Mellitin, resulted in
arachidonic acid release, which was significantly reduced by the addition of
glycine. Glutamine and alanine, given at the same concentrations, were not
protective against this phospholipase Ar-induced injury. It appeared that glycine
inhibits a hypoxia-induced, phospholipase Ar-rnediated arachidonic acid
release.
These data are of interest, since after renal ischemia, arachidonic acid is
normally metabolized during reperfusion to vasoconstrictive eicosanoids, such
as thromboxane Ar. Vasoconstriction may result in decreased blood flow and
subsequently lead to tubular necrosis. Prevention of the potential danger of
postreperfusion organ failure by addition of glycine would have important
consequences in clinical transplantation.
CHeprEn VI
Chapter VI describes the effect of the use of glycine in a dog kidney transplant
model. In a preliminary study (Chapter In 15 mM/L glycine was not a good
replacement of 3 mMÀ glutathione (GSH) in UW solution for kidney
preservation. As published in this same chapter, however, l0 mM/L glycine had
a protective effect on cold stored (0-72 h) kidney slices, when added to the
rewarming medium KHB, simulating a reperfusion model. We were interested
to see if glycine could equal this cytoprotective effect in a blood revascularized
transplant model, when given at the time of reperfusion to the recipient of a dog
kidney after cold storage for 72 h in UW solution without GSH. Therefore, we
preserved kidneys for 72 h at 40C in UW solution with and without GSH and
distinguished 5 study groups: Group I: UW solution with fresh GSH (3 mM/L),
t L 3
Chapter IX
Group II: UW solution without GSH, Group III: UW solution without GSH, but
with 15 mM/L glycine, Group IV; UW solution without GSH. but 3 mM/L
glycine given to the recipient, Group V: UW solution without GSH. but 15
mM/L glycine given to the recipient.
This study confirms the results of preliminary studies: GSH is an essential
component of UW solution. Omission of glutathione in UW solution shows a
decrease in survival (Group II vs. Group I:640Á vs.100%) and increased serum
creatinine levels post-transplant. Glycine in UW solution is not a good
replacement for glutathione (Group III): sur-vival increased to l00oÁ, but
recovery time of transplanted kidneys, expressed in serum creatinine level post-
transplant, was worse, compared to cold storage in UW solution with glutathi-
one (Group I).
The administration of glycine at time of reperfusion to recipients of
transplanted kidneys, cold stored in UW solution without glutathione, did show
100%o survival (Group IV and Group V). A low concentration of glycine (3
rnM/L), however, showed the same results as cold stored kidneys in UW
solution without GSH (group II) as expressed in post-transplant creatinine
levels, but survival was 100%. Administration of l5 mM/aL glycine decreased
serurr creatinine levels to normal and survival was also 100% (Group V).
We conclude that cold storage of kidneys in UW solution with fresh GSH is
the best preservation method. Administration of l5 mM/aL glycine at time of
reperfusion to recipients of kidneys can compete with the results of preservation
in UW solution with GSH, but creates no additional cytoprotective effect.
CHAPTER VII
Glycine has been shown to decrease membrane injury in isolated cells due to
hypoxia or cold ischemia. The mechanisms of action of glycine are not known,
but glycine may be useful in organ preservation solutions or in treating
recipients of liver transplantation.
In this study the isolated perfused rabbit liver was used to measure how
glycine affected liver performance after 48 h preservation in the University of
Wisconsin (UW) solution without added glutathione. UW solution is less
effective for 48 h liver preservation when glutathione is omitted. Rabbit livers
stored for 48 h without glutathione show a large increase in enzyme release
(LDH and AST) from the liver and a reduction in bile production. The addition
of 15 mM/L glycine to the UW solution, instead of glutathione, did not improve
bile production or reduce enzyme release. However, infusion of 10 mM/L







































r without GSH, but
iSH. but 3 rnM/L
hout GSH. but 15
iSH is an essential
y' solution shows a
nd increased serum
rn is not a good
sed to 100%, but
eatinine level post-
rtion with glutathi-
r to recipients of
rtathione, did show
ation oi glycine (3




r with fresh GSH is
glycine at time of
ults of preservation
:ctive effect.
olated cells due to
ine are not known,
)ns or in treating
J to measure how
r the University of




e, did not improve
;ion of 10 mM/L
icantly during the
Summary
reperfusion of the 48 h preserved liver. Hepatamine, a parenteral nutrition
solution containing glycine, as well as other amino acids, was also effective in
lowering LDH release fiom the preserved liver.
Although glycine reduced LDH release, it did not decrease the amount of
AST released from the liver, nor did it improve bile production. Thus. we
conclude that glycine, either in UW solution or given to the liver upon
reperfusion. has no significantly beneficial effect as tested in this model. Further
testing of glycine, however, should be conducted in an orthotopic transplant
model in the rat or dos.
Cuap'r'pn VIII
Glycine has been shown to protect renal tubule cells and hepatocytes frorn
ischemia, ATP depletion, and cold storage injury. Glycine may be a useful
additive to organ preservation solutions or suppress reperfusion injury by
infusion into recipients of liver transplantation. In this study the effects of
glycine on survival and post-operative liver injury was studied in the rat and
dog orthotopic transplant model. Rat livers preserved for 30 h in the UW
solution were 50%o viable (3 of 6 suruivors for seven days). When glutathione
was replaced by 10 mM glycine survival increased to 100%o (6 of 6). There was
a significant reduction in hepatocellular injury at the end of preservation (LDH
in the pre-transplant flushout of the liver was lower in the glycine group) and
after transplantation (serum LDH concentration 6 h post-transplant was lower in
the glycine group). ln the dog, omission of glutathione from the UW solution
resulted in 33%o survival (48 h preservation model) versus 100% survival with
glutathione. Replacing glutathione in the UW solution by glycine did not
improve survival (33oÁ after 48 h preservation). However, when glycine was
given to recipients of livers preserved in the UW solution for 24 or 48 h, there
was a decrease in the degree of hepatocellular injury. After 48 h preservation,
peak AST, ALT, and LDH were reduced by about 45 to 55oÁ when glycine was
given to the recipient. Although the differences, with and without glycine
treatment of the recipients, did not reach statistical significance, there was a
noticeable reduction in hepatocellular injury with glycine. There was 100%
survival of dogs in the groups that received livers preserued with the UW
solution plus or minus glycine infusion. Hepatamine, a parenteral nutrition
solution containing glycine and other amino acids, increased hepatocellular
injury (higher concentrations of AST, ALT, and LDH, versus control 48 h
preserved livers) although all dogs survived. This study shows that glycine is
cytoprotective when administered to recipients of livers preserved for 24 or 48 h
tz5
Chapter IX
and suppressed hepatocellular injury as reflected in a reduction in the
concentration of serum enzymes. Howevern the differences, with and without
glycine, were at best marginal and further studies are needed to determine if
glycine would make a significant improvement in liver preservation and prevent
primary non function.
f
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